multidrug therapy
Factors associated with non adherence to leprosy multidrug therapy: a review
... Despite treatment and cure, leprosy remains a serious public health problem, especially in developing countries (NORIEGA et al., 2016). To reverse this situation, it is necessary that the diagnosis occurs preferably in ...
5
Can baseline ML Flow test results predict leprosy reactions? An investigation in a cohort of patients enrolled in the uniform multidrug therapy clinical trial for leprosy patients in Brazil
... after multidrug therapy (MDT), acute immune-inflammatory episodes, known as type 1 reac- tions or reversal reaction (RR) and type 2 reactions represented mainly by erythema nodosum leprosum (ENL), can lead ...
10
Interruption and defaulting of multidrug therapy against leprosy: population-based study in Brazil's Savannah region
... Interruption and Defaulting of Multidrug Therapy against Leprosy: Population-Based Study in Brazil’s Savannah Region Jorg Heukelbach1,2*, Olga Andre´ Chichava1, Alexcian Rodrigues de Oli[r] ...
9
Adverse reactions in leprosy patients who underwent dapsone multidrug therapy: a retrospective study
... Objective: To investigate the occurrence and clinical characteristics of dapsone-related adverse drug reactions (ADRs) among leprosy patients who underwent multidrug therapy (MDT) from[r] ...
6
Understanding non-compliance with WHO-multidrug therapy among leprosy patients in Assam, India.
... Objectives: The study was undertaken to assess the adherence to World Health Organization (WHO)-multidrug therapy (MDT) and its successful completion by the leprosy patients and the extent of such ...
5
Clinical efficacy and safety of multidrug therapy including thrice weekly intravenous amikacin administration for Mycobacterium abscessus pulmonary disease in outpatient settings: a case series
... All patients were negative for HIV. None of the patients were excluded during the observation period. Patient background data are shown in Table 1. There were 2 men and 11 women. The mean age at the initiation of ...
9
HIV-1 mutational pathways under multidrug therapy
... Data for the study came from a large observational database. This can lead to several forms of bias in the data. While we believe these effects to be small, they should be noted. The first bias deals with model ...
13
Perspectives on the impact of stigma in leprosy: strategies to improve access to health care
... social multidrug therapy similar to the medical multidrug therapy, where there would be one arm for curing the medical problems of leprosy, a second arm focusing on empowering the people, ...
9
Population wide administration of single dose rifampicin for leprosy prevention in isolated communities: a three year follow up feasibility study in Indonesia
... DOCX 13 kb Abbreviations G2D: Grade II Disability; LPEP: Leprosy Post Exposure Prophylaxis; MB: Multibacillary; MDT: Multidrug therapy; NLCP: National Leprosy Control Programme; PB: Pauc[r] ...
8
Spatial distribution and temporal trends of leprosy in Uganda, 2012–2016: a retrospective analysis of public health surveillance data
... Leprosy, also known as Hansen’s disease, is a chronic bacterial infection caused by Mycobacterium leprae. The disease may affect the nerves, skin, eyes, and nasal mu- cosa; if left untreated, nerve damage may cause ...
8
Comparative Genomics for the Elucidation of Multidrug Resistance in Candida lusitaniae
... C andida (teleomorph Clavispora) lusitaniae is a ubiquitous ascomycetous yeast that can be recovered from soils and water but can survive in different hosts (birds and mammals). It is known as an opportunistic haploid ...
22
Download Download PDF
... Over the past decades, the frequency of antimicrobial resis- tance has increased globally. MDR bacteria are now recognized as a major cause of nosocomial infections, representing a serious safety concern for both health ...
8
Effectiveness of tigecycline based versus colistin based therapy for treatment of pneumonia caused by multidrug resistant Acinetobacter baumanniiin a critical setting: a matched cohort analysis
... replacement therapy [7,22]. Combin- ation therapy was defined as at least 3 days of concur- rent use of the antimicrobial agent other than colistin or ...
8
Multidrug Resistance in Neisseria gonorrhoeae: Identification of Functionally Important Residues in the MtrD Efflux Protein
... Antibiotic resistance in N. gonorrhoeae is an effective survival strategy, as this bacterium has been successful in developing resistance to almost all antibiotics previ- ously or currently used for treatment of ...
14
Multidrug resistance, inappropriate empiric therapy, and hospital mortality in Acinetobacter baumannii pneumonia and sepsis
... Methods: We conducted a retrospective cohort study using the Premier Research database (2009 – 2013) of 175 U.S. hospitals. We included all adult patients admitted with pneumonia or sepsis as their principal diagnosis, ...
10
“Molecular Studies on Escherichia coli isolated from Diarrheic Dog” by Aisha R. Ali, Mona A. El Shehedi, Mostafa M. Eraqi, Egypt.
... In conclusion, E.coli one of most causes of diarrhea in dogs cross infection may occurred to human so diarrheic dogs must be well diagnosed and must be apply sensitivity test against isolated pathogens to correct ...
8
Emergence of a Potent Multidrug Efflux Pump Variant That Enhances Campylobacter Resistance to Multiple Antibiotics
... Results of this study also reveal a clear rising trend in the prev- alence of RE-CmeABC in C. jejuni (Table 2). The difference in the prevalence of RE-cmeABC between C. jejuni and C. coli is probably due to the fact that ...
11
Selection of a Multidrug Resistance Plasmid by Sublethal Levels of Antibiotics and Heavy Metals
... the multidrug resistance plasmid can occur at concentra- tions far below the MIC of a susceptible strain and that this general pattern is observed for many different classes of antibiotics and heavy ...
9
Multidrug Resistance in Fungi
... the multidrug-resistant phenotype ...but multidrug resistance has only been assessed for ...reversible multidrug-resistant status of the three ...reversible multidrug resis- ...robust ...
10
Efficacy and safety of tenofovir in a kidney transplant patient with chronic hepatitis B and nucleos(t)ide multidrug resistance: a case report
... rejection therapy after kidney ...rescue therapy increases the risk of developing HBV multidrug ...caused multidrug resistance and renal functional ...combination therapy with entecavir ...
6